Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
2301 | 4109 | 26.6 | 51% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
334 | 33102 | BONE MARROW TRANSPLANTATION//GRAFT VERSUS HOST DISEASE//BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
9600 | 1072 | LDL APHERESIS//LOW DENSITY LIPOPROTEIN APHERESIS//LIPOPROTEIN APHERESIS |
10150 | 1024 | THERAPEUTIC APHERESIS//THERAPEUTIC PLASMA EXCHANGE//PLASMA EXCHANGE |
12678 | 826 | THEODORE GILDRED CANC//PROTEIN L//STAPHYLOCOCCAL PROTEIN A |
19721 | 428 | ANIM PHYSIOL SECT//PROSORBA//PROTEIN A IMMOBILIZATION |
20921 | 379 | BILIRUBIN REMOVAL//BILIRUBIN ADSORPTION//SPECIFIC SORBENTS |
25588 | 229 | CHITOSAN COATED DIALDEHYDE CELLULOSE//IMMOBILIZED UREASE//CONTINUOUS ARTERIOVENOUS HEMOPERFUSION |
33851 | 83 | LEONARD DIANE SHERMAN BIOMAT//PLASMAPHORESIS//AVIDIN COLUMN |
34549 | 68 | MULTIVALENT IMMUNOTOXINS//KINETIC PARAMETERS OF BINDING//CHRONIC LYMPHOLEUKEMIA |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | LDL APHERESIS | Author keyword | 217 | 69% | 5% | 185 |
2 | LOW DENSITY LIPOPROTEIN APHERESIS | Author keyword | 98 | 79% | 2% | 62 |
3 | APHERESIS | Author keyword | 30 | 22% | 3% | 121 |
4 | LIPOPROTEIN APHERESIS | Author keyword | 30 | 60% | 1% | 32 |
5 | THERAPEUTIC APHERESIS | Author keyword | 27 | 51% | 1% | 38 |
6 | IMMUNOADSORPTION | Author keyword | 26 | 24% | 2% | 95 |
7 | MEMBRANE DIFFERENTIAL FILTRATION | Author keyword | 23 | 100% | 0% | 10 |
8 | LIPID APHERESIS | Author keyword | 22 | 62% | 1% | 23 |
9 | JOURNAL OF CLINICAL APHERESIS | Journal | 22 | 17% | 3% | 121 |
10 | BILIRUBIN REMOVAL | Author keyword | 19 | 76% | 0% | 13 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | LDL APHERESIS | 217 | 69% | 5% | 185 | Search LDL+APHERESIS | Search LDL+APHERESIS |
2 | LOW DENSITY LIPOPROTEIN APHERESIS | 98 | 79% | 2% | 62 | Search LOW+DENSITY+LIPOPROTEIN+APHERESIS | Search LOW+DENSITY+LIPOPROTEIN+APHERESIS |
3 | APHERESIS | 30 | 22% | 3% | 121 | Search APHERESIS | Search APHERESIS |
4 | LIPOPROTEIN APHERESIS | 30 | 60% | 1% | 32 | Search LIPOPROTEIN+APHERESIS | Search LIPOPROTEIN+APHERESIS |
5 | THERAPEUTIC APHERESIS | 27 | 51% | 1% | 38 | Search THERAPEUTIC+APHERESIS | Search THERAPEUTIC+APHERESIS |
6 | IMMUNOADSORPTION | 26 | 24% | 2% | 95 | Search IMMUNOADSORPTION | Search IMMUNOADSORPTION |
7 | MEMBRANE DIFFERENTIAL FILTRATION | 23 | 100% | 0% | 10 | Search MEMBRANE+DIFFERENTIAL+FILTRATION | Search MEMBRANE+DIFFERENTIAL+FILTRATION |
8 | LIPID APHERESIS | 22 | 62% | 1% | 23 | Search LIPID+APHERESIS | Search LIPID+APHERESIS |
9 | BILIRUBIN REMOVAL | 19 | 76% | 0% | 13 | Search BILIRUBIN+REMOVAL | Search BILIRUBIN+REMOVAL |
10 | PLASMA EXCHANGE | 16 | 12% | 3% | 127 | Search PLASMA+EXCHANGE | Search PLASMA+EXCHANGE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | LDL APHERESIS | 173 | 60% | 5% | 189 |
2 | LIPID APHERESIS | 51 | 79% | 1% | 33 |
3 | ANGIOGRAPHICALLY ASSESSED TRIAL | 45 | 83% | 1% | 25 |
4 | DENSITY LIPOPROTEIN APHERESIS | 45 | 56% | 1% | 55 |
5 | PLASMAPHERESIS | 28 | 14% | 4% | 182 |
6 | DALI APHERESIS | 24 | 91% | 0% | 10 |
7 | PRECIPITATION HELP | 23 | 76% | 0% | 16 |
8 | LDL PRECIPITATION HELP | 21 | 90% | 0% | 9 |
9 | THERAPEUTIC APHERESIS | 21 | 46% | 1% | 33 |
10 | CELLULOSE ADSORPTION SYSTEM | 20 | 100% | 0% | 9 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | JOURNAL OF CLINICAL APHERESIS | 22 | 17% | 3% | 121 |
2 | PLASMA THERAPY & TRANSFUSION TECHNOLOGY | 18 | 24% | 2% | 63 |
3 | THERAPEUTIC APHERESIS | 16 | 29% | 1% | 46 |
4 | ATHEROSCLEROSIS SUPPLEMENTS | 9 | 17% | 1% | 47 |
5 | TRANSACTIONS AMERICAN SOCIETY FOR ARTIFICIAL INTERNAL ORGANS | 9 | 11% | 2% | 73 |
6 | BIOMATERIALS ARTIFICIAL CELLS AND ARTIFICIAL ORGANS | 6 | 14% | 1% | 36 |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Recommendations for the use of LDL apheresis | 2008 | 122 | 46 | 91% |
LDL apheresis | 2003 | 99 | 84 | 83% |
A systematic review of LDL apheresis in the treatment of cardiovascular disease | 2006 | 37 | 41 | 78% |
Lipoprotein apheresis: an update | 2013 | 8 | 76 | 68% |
Confounding B-cell defences: lessons from a staphylococcal superantigen | 2006 | 67 | 94 | 39% |
Liver transplant combined with heart transplant in severe heterozygous hypercholesterolemia: Report of the first case and review of the literature | 2005 | 19 | 8 | 100% |
Current management of severe homozygous hypercholesterolaemias | 2004 | 52 | 79 | 52% |
Efficacy criteria and cholesterol targets for LDL apheresis | 2010 | 42 | 23 | 48% |
Drug removal by plasmapheresis: An evidence-based review | 2007 | 31 | 64 | 63% |
BINDING OF IMMUNOGLOBULINS TO PROTEIN-A AND IMMUNOGLOBULIN LEVELS IN MAMMALIAN SERA | 1983 | 359 | 34 | 65% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ANIM PHYSIOL SECT | 11 | 67% | 0.2% | 10 |
2 | PLASM HE IS UNIT | 10 | 63% | 0.2% | 10 |
3 | THEODORE GILDRED CANC | 9 | 83% | 0.1% | 5 |
4 | HE IS UNIT | 5 | 26% | 0.4% | 17 |
5 | RD IMMUNOESSAIS PROTEOM | 4 | 75% | 0.1% | 3 |
6 | EXTRACORPOREAL THER EUT TECH UNIT | 4 | 46% | 0.1% | 6 |
7 | DOUBLE CHECK SWISS | 3 | 100% | 0.1% | 3 |
8 | HEM HE IS UNIT | 2 | 44% | 0.1% | 4 |
9 | AUTON NEUROENDOCRINOL | 2 | 36% | 0.1% | 5 |
10 | MED METAB CARE GERONTOL 3 | 2 | 67% | 0.0% | 2 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000030692 | EXTRACORPOREAL PHOTOCHEMOTHERAPY//PHOTOPHERESIS//EXTRACORPOREAL PHOTOPHERESIS |
2 | 0.0000019424 | EXPERIMENTAL LEPROSY//IGA ALPHA 1 ANTITRYPSIN COMPLEX//IGA ALPHA1 ANTITRYPSIN COMPLEX |
3 | 0.0000015404 | LIPOPROTEINA//APOLIPOPROTEINA//LIPOPROTEIN A |
4 | 0.0000010530 | THROMBOTIC THROMBOCYTOPENIC PURPURA//ADAMTS 13//HEMOLYTIC UREMIC SYNDROME |
5 | 0.0000009771 | AQUEOUS TWO PHASE SYSTEMS//AQUEOUS TWO PHASE SYSTEM//EXPANDED BED ADSORPTION |
6 | 0.0000007457 | GUILLAIN BARRE SYNDROME//CASTLEMANS DISEASE//POEMS SYNDROME |
7 | 0.0000006702 | FCRN//NEONATAL FC RECEPTOR//FC GAMMA RECEPTORS |
8 | 0.0000006547 | MYASTHENIA GRAVIS//AGRIN//ACETYLCHOLINE RECEPTORS |
9 | 0.0000006383 | CLINICAL HEMORHEOLOGY//CLINICAL HEMORHEOLOGY AND MICROCIRCULATION//ERYTHROCYTE AGGREGATION |
10 | 0.0000006312 | STREPTOCOCCUS SUIS//GROUP A STREPTOCOCCI//STREPTOCOCCUS PYOGENES |